ADAM vs EQIX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ADAM's Piotroski F-Score of 4/9 indicates weak financial health, falling into the 'Weak' category, while the absence of an Altman Z-Score raises unquantified distress risk. Despite a high Graham Number of $15.59 and a current price of $7.87, the stock trades at a significant discount, but this is likely due to extreme financial instability. The company exhibits a 18,963.6% YoY revenue surge, yet earnings remain volatile and negative in multiple quarters, with a recent -36.1% Q/Q EPS decline. The 78.18% payout ratio on a highly erratic earnings base raises serious dividend sustainability concerns, undermining the 10.93% yield as a defensive feature.
EQIX shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
ADAM vs EQIX: Head-to-Head Comparison
This page compares Adamas Trust, Inc. (ADAM) and Equinix, Inc. (EQIX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.